198 related articles for article (PubMed ID: 7719932)
1. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.
Barr D; Tubb J; Ferguson D; Scaria A; Lieber A; Wilson C; Perkins J; Kay MA
Gene Ther; 1995 Mar; 2(2):151-5. PubMed ID: 7719932
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression.
Michou AI; Santoro L; Christ M; Julliard V; Pavirani A; Mehtali M
Gene Ther; 1997 May; 4(5):473-82. PubMed ID: 9274725
[TBL] [Abstract][Full Text] [Related]
3. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
5. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver.
Tao N; Gao GP; Parr M; Johnston J; Baradet T; Wilson JM; Barsoum J; Fawell SE
Mol Ther; 2001 Jan; 3(1):28-35. PubMed ID: 11162308
[TBL] [Abstract][Full Text] [Related]
6. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity.
Schiedner G; Morral N; Parks RJ; Wu Y; Koopmans SC; Langston C; Graham FL; Beaudet AL; Kochanek S
Nat Genet; 1998 Feb; 18(2):180-3. PubMed ID: 9462752
[TBL] [Abstract][Full Text] [Related]
7. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice.
Schowalter DB; Himeda CL; Winther BL; Wilson CB; Kay MA
J Virol; 1999 Jun; 73(6):4755-66. PubMed ID: 10233936
[TBL] [Abstract][Full Text] [Related]
8. Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.
Fang B; Wang H; Gordon G; Bellinger DA; Read MS; Brinkhous KM; Woo SL; Eisensmith RC
Gene Ther; 1996 Mar; 3(3):217-22. PubMed ID: 8646552
[TBL] [Abstract][Full Text] [Related]
9. Macrophage depletion increases the safety, efficacy and persistence of adenovirus-mediated gene transfer in vivo.
Kuzmin AI; Finegold MJ; Eisensmith RC
Gene Ther; 1997 Apr; 4(4):309-16. PubMed ID: 9176516
[TBL] [Abstract][Full Text] [Related]
10. Immune responses limit adenovirally mediated gene expression in the adult mouse eye.
Reichel MB; Ali RR; Thrasher AJ; Hunt DM; Bhattacharya SS; Baker D
Gene Ther; 1998 Aug; 5(8):1038-46. PubMed ID: 10326026
[TBL] [Abstract][Full Text] [Related]
11. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
Van Linthout S; Lusky M; Collen D; De Geest B
Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
[TBL] [Abstract][Full Text] [Related]
12. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
[TBL] [Abstract][Full Text] [Related]
13. Heterologous expression of adenovirus E3-gp19K in an E1a-deleted adenovirus vector inhibits MHC I expression in vitro, but does not prolong transgene expression in vivo.
Schowalter DB; Tubb JC; Liu M; Wilson CB; Kay MA
Gene Ther; 1997 Apr; 4(4):351-60. PubMed ID: 9176522
[TBL] [Abstract][Full Text] [Related]
14. A mouse model of arterial gene transfer: antigen-specific immunity is a minor determinant of the early loss of adenovirus-mediated transgene expression.
Vassalli G; Agah R; Qiao R; Aguilar C; Dichek DA
Circ Res; 1999 Oct; 85(9):e25-32. PubMed ID: 10532959
[TBL] [Abstract][Full Text] [Related]
15. Sustained expression of human apo A-I following adenoviral gene transfer in mice.
De Geest B; Van Linthout S; Collen D
Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer.
Guo ZS; Wang LH; Eisensmith RC; Woo SL
Gene Ther; 1996 Sep; 3(9):802-10. PubMed ID: 8875229
[TBL] [Abstract][Full Text] [Related]
17. Strain-specific rate of shutdown of CMV enhancer activity in murine liver confirmed by use of persistent [E1(-), E2b(-)] adenoviral vectors.
Everett RS; Evans HK; Hodges BL; Ding EY; Serra DM; Amalfitano A
Virology; 2004 Jul; 325(1):96-105. PubMed ID: 15231389
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes.
Kay MA; Graham F; Leland F; Woo SL
Hepatology; 1995 Mar; 21(3):815-9. PubMed ID: 7875680
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
20. Lipid emulsions potently increase transgene expression in hepatocytes after adenoviral transfer.
Snoeys J; Mertens G; Lievens J; van Berkel T; Collen D; Biessen EA; De Geest B
Mol Ther; 2006 Jan; 13(1):98-107. PubMed ID: 16112619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]